| 货号 | 16131-100mg |
| 描述 | Rifaximin is an antibiotic derived from rifamycin that targets most Gram-positive and Gram-negative bacteria.1 As it is poorly absorbed after oral administration, it is effective in eliminating bacteria in the gastrointestinal system, including those involved in intestinal inflammatory diseases.2,3,4,5,6 |
| 别名 | L 105SV;Rifamycin L 105;Xifaxan®; |
| 供应商 | Cayman |
| 应用文献 | |
| 1.Steffen, R. Rifaximin: A nonabsorbed antimicrobial as a new tool for treatment of travelers diarrhea. J.Travel Med. 8(suppl 2), S34-S39 (2001). 2.Alajbegovic, S.,Sanders, J.W.,Atherly, D.E., et al. Effectiveness of rifaximin and fluoroquinolones in preventing travelers diarrhea (TD): A systematic review and meta-analysis. Syst.Rev. 1, 39 (2012). 3.Song, M. and Ang, T.L. Second and third line treatment options for Helicobacter pylori eradication. World Journal of Gastroenterology 20(6), 1517-1528 (2014). 4.Scribano, M.L. and Prantera, C. Use of antibiotics in the treatment of Crohn’s disease. World Journal of Gastroenterology 19(5), 648-653 (2013). 5.Oldfield, E.C.I.,Oldfield, E.C., III and Johnson, D.A. Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J.Gastroenterol.Pharmacol.Ther. 5(1), 1-26 (2014). 6.Kimer, N.,Krag, A. and Gluud, L.L. Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy. Patient Prefer.Adherence 8, 331-338 (2014). | |
| 运输条件 | Wet ice in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 785.9 |
| 分子式 | C43H51N3O11 |
| CAS号 | 80621-81-4 |
| 稳定性 | ≥ 2 years |
| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |